Intchains Group
ICG
SATO TECHNOLOGIES CORP
CCPUF
BIGG DIGITAL ASSETS INC
BBKCF
FRMO CORP
FRMO
Bitfarms
BITF
US Stock MarketDetailed Quotes
RARE Ultragenyx Pharmaceutical
- 43.420
- -0.400-0.91%
Close Dec 27 16:00 ET
- 43.420
- 0.0000.00%
Post 20:01 ET
4.01BMarket Cap-6.84P/E (TTM)
44.070High42.840Low686.52KVolume43.805Open43.820Pre Close29.80MTurnover0.77%Turnover RatioLossP/E (Static)92.34MShares60.37052wk High11.56P/B3.87BFloat Cap37.02052wk Low--Dividend TTM89.11MShs Float179.647Historical High--Div YieldTTM2.81%Amplitude31.520Historical Low43.407Avg Price1Lot Size
About Ultragenyx Pharmaceutical Company
Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.
Company Profile
SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing DateJan 31, 2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1276
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800
Websitehttp://www.ultragenyx.com
Company Executives
- Name
- Position
- Salary
- Dr. Emil D. Kakkis, M.D.,PhD
- Director, President, Chief Executive Officer
- 13.08M
- Dr. Eric Crombez, M.D.
- Executive Vice President and Chief Medical Officer
- --
- John Richard Pinion, II
- Chief Quality Officer and Executive Vice President, Translational Sciences
- 4.05M
- Thomas R. Kassberg
- Chief Business Officer and Executive Vice President
- --
- Erik Harris
- Chief Commercial Officer and Executive Vice President
- 4.07M
- Dennis Karl Huang
- Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
- --
- Karah Parschauer
- Chief Legal Officer and Executive Vice President, Corporate Affairs
- 4.04M
- Howard Horn
- Chief Financial Officer and Executive Vice President, Corporate Strategy
- 5.94M
- Theodore A. Huizenga
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Daniel G. Welch
- Chairman of the Board
- 499.89K
- Dr. Corazon Dating Sanders, PhD
- Independent Director
- 469.39K
- Dr. Amrit Ray, M.D.
- Independent Director
- 460.39K
- Dr. Deborah L. Dunsire,M.D.
- Independent Director
- 459.89K
- Michael A. Narachi
- Independent Director
- 482.39K
- Dr. Shehnaaz Suliman, M.D.
- Independent Director
- 466.89K
- Matthew K. Fust
- Independent Director
- 479.89K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.